Suerte, Baby Charlyn P.
HRN: 22-01-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2024
MUPIROCIN 2%, 15G (TUBE)
12/02/2024
12/09/2024
TOPICAL
2%
TID
Second Degree Burn
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes